MedTrace Logo

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

NCT05300542 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-04-06

No results posted yet for this study

Summary

The aim of this study is to determine the erythema-reducing efficacy of a test product in two concentrations on a light sunburn induced by a sun simulator compared to an untreated control and a placebo product.

Conditions

  • Erythema
  • Sun Damaged Skin
  • Skin Inflammation

Interventions

OTHER

Topical Placebo Cream

Application of test products before and after irradiation

OTHER

Topical Cream with 0.5% Active

Application of test products before and after irradiation

OTHER

Topical Cream with 1% Active

Application of test products before and after irradiation

Sponsors & Collaborators

  • proDERM GmbH

    collaborator INDUSTRY

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Prof. Dr. med. Klaus-Peter Wilhelm, Dermatologist, MD · proDERM GmbH

  • Dr. rer. nat. Sabrina Laing, MD · proDERM GmbH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-17
Primary Completion
2022-03-31
Completion
2022-04-13

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300542 on ClinicalTrials.gov